Published in Dementia on November 16, 1993
A longitudinal study of sentence comprehension difficulty in primary progressive aphasia. J Neurol Neurosurg Psychiatry (2005) 1.00
Cognition, language, and clinical pathological features of non-Alzheimer's dementias: an overview. J Commun Disord (2010) 0.79
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry (2001) 2.50
Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain (2006) 2.00
Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry (1986) 1.83
Progressive language disorder due to lobar atrophy. Ann Neurol (1992) 1.82
Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett (1992) 1.82
Sub-clinical entrapment neuropathy in man. J Neurol Sci (1975) 1.78
Knowledge of famous faces and names in semantic dementia. Brain (2004) 1.68
Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry (1993) 1.62
Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry (1999) 1.55
Psychomotor, executive, and memory function in preclinical Huntington's disease. J Clin Exp Neuropsychol (2002) 1.51
Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 1.51
Distinct neuropsychological characteristics in Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2002) 1.48
Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol Scand (2001) 1.47
Inter-relation between "classic" motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry (1995) 1.37
Social cognition in frontotemporal dementia and Huntington's disease. Neuropsychologia (2003) 1.37
Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry (1986) 1.36
Development of extrapyramidal symptoms in hypertensive patients treated with diazoxide. Br Med J (1973) 1.36
Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain (2002) 1.32
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem (1983) 1.28
Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem (1983) 1.28
Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.25
The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathol Appl Neurobiol (1988) 1.19
Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia. Acta Neurol Scand (2002) 1.18
Primary angiitis of the central nervous system: emerging variants. QJM (2005) 1.16
Awareness of involuntary movements in Huntington disease. Arch Neurol (1998) 1.16
Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J Neurochem (1987) 1.09
Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann Neurol (1999) 1.05
Emotion recognition in Huntington's disease and frontotemporal dementia. Neuropsychologia (2008) 1.05
Progressive aphasia with right-sided extrapyramidal signs: another manifestation of localised cerebral atrophy. J Neurol Neurosurg Psychiatry (1989) 1.03
Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res (1987) 1.00
Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. N Engl J Med (1985) 1.00
Chromosome 14 linked familial Alzheimer's disease. A clinico-pathological study of a single pedigree. Brain (1995) 0.99
Alterations in protein synthetic capability of nerve cells in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1981) 0.98
Activation of a cellular transforming gene in tumours induced by Abelson murine leukaemia virus. Nature (1982) 0.97
Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J Neurochem (1988) 0.97
Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease. Lancet (1980) 0.96
The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. J Neurol (1995) 0.96
The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males. J Neurol Neurosurg Psychiatry (2006) 0.95
A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? J Neurol Neurosurg Psychiatry (1998) 0.94
Alzheimer's disease as a disorder of isodendritic core. Lancet (1982) 0.94
Longitudinal evaluation of cognitive disorder in Huntington's disease. J Int Neuropsychol Soc (2001) 0.92
The thoracic outlet syndrome. Brain (1977) 0.92
Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry (2006) 0.91
Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease. Acta Neuropathol (1992) 0.91
The cause of nerve damage in acute compression. Trans Am Neurol Assoc (1974) 0.90
Renaut body distribution at sites of human peripheral nerve entrapment. J Neurol Sci (1981) 0.90
Arithmetic knowledge in semantic dementia: is it invariably preserved? Neuropsychologia (2008) 0.89
Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry (1984) 0.89
Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur J Nucl Med (1994) 0.89
Non Alzheimer's disease forms of cerebral atrophy. J Neurol Neurosurg Psychiatry (1990) 0.88
A 99mTc-HMPAO single-photon emission computed tomography study of Lewy body disease. J Neurol (1997) 0.86
Abnormalities of motor timing in Huntington's disease. Parkinsonism Relat Disord (1996) 0.85
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy. Psychopharmacology (Berl) (2007) 0.85
Neurofibrillary pathology and protein synthetic capability in nerve cells in Alzheimer's disease. Neuropathol Appl Neurobiol (1981) 0.84
Pathological changes in the brain of a patient with familial Alzheimer's disease having a missense mutation at codon 717 in the amyloid precursor protein gene. Neurosci Lett (1992) 0.84
Apolipoprotein E allelic frequencies in patients with lobar atrophy. Neurosci Lett (1995) 0.83
Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neuroscience (1990) 0.83
Inferring thought and action in motor neurone disease. Neuropsychologia (2006) 0.83
Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Brain (1987) 0.83
The long-term outcome of head injury: implications for service planning. Brain Inj (1995) 0.82
Letter: Localized hypertrophic neuropathy, intraneural tumour, or chronic nerve entrapment? Lancet (1975) 0.82
Apolipoprotein E epsilon4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with pick- or microvacuolar-type histology. Exp Neurol (2000) 0.82
Autopsy proven sporadic frontotemporal dementia due to microvacuolar-type histology, with onset at 21 years of age. J Neurol Neurosurg Psychiatry (2004) 0.81
Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease. Brain Res (1983) 0.81
Neuropsychiatric aspects of frontotemporal dementias. Curr Psychiatry Rep (1999) 0.81
Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype. J Neurol Neurosurg Psychiatry (2006) 0.81
An ultrastructural analysis of the effects of accumulation of neurofibrillary tangle in pyramidal neurons of the cerebral cortex in Alzheimer's disease. Neuropathol Appl Neurobiol (1986) 0.81
Tau pathology in a case of familial Alzheimer's disease with a valine to glycine mutation at position 717 in the amyloid precursor protein. Neurosci Lett (1992) 0.80
Somatostatin content and release measured in cerebral biopsies from demented patients. J Neurol Sci (1987) 0.80
Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease. Brain Res (1987) 0.80
Soluble beta-amyloid precursor protein and pyramidal neuron loss. Lancet (1993) 0.80
Long term memory for famous voices in amnesic and normal subjects. Neuropsychologia (1980) 0.80
Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry (1985) 0.79
Do amnesics adopt inefficient encoding strategies with faces and random shapes? Neuropsychologia (1980) 0.79
Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression. J Neurol Neurosurg Psychiatry (1993) 0.79
Autobiographical experience and word meaning. Memory (1996) 0.79
Diagnostic value of high signal abnormalities on T2 weighted MRI in the differentiation of Alzheimer's, frontotemporal and vascular dementias. Acta Neurol Scand (2002) 0.79
Coexistence of systemic sclerosis and multiple sclerosis. J Neurol (2004) 0.78
A quantitative study of the ultrastructure of pyramidal neurons of the cerebral cortex in Alzheimer's disease in relationship to the degree of dementia. Neuropathol Appl Neurobiol (1986) 0.78
DNA repair in lymphocytes from young and old individuals and from patients with Alzheimer's disease. Mutat Res (1987) 0.78
Metabolic processes in Alzheimer's disease: adenine nucleotide content and production of 14CO2 from [U-14C]glucose in vitro in human neocortex. J Neurochem (1983) 0.77
Phosphofructokinase activity in the brain in Alzheimer's disease. Ann Neurol (1987) 0.77
Treatment of Alzheimer's disease: a cautionary note. N Engl J Med (1981) 0.77
The electroencephalogram in dementia with Lewy bodies. Acta Neurol Scand (2000) 0.76
The use of [99mTc]-HM-PAO in the diagnosis of primary degenerative dementia. J Cereb Blood Flow Metab (1988) 0.75
Subcortical vascular disease in elderly patients with treatment resistant depression. J Neurol Neurosurg Psychiatry (1997) 0.75
Glutamatergic denervation in Alzheimer's disease--a cautionary note. J Neurol Neurosurg Psychiatry (1987) 0.75
Creutzfeldt-Jakob disease: a histochemical study with microdensitometric assay of some enzymes. Acta Neuropathol (1973) 0.75
Shy-Drager syndrome presenting as isolated paralysis of vocal cord abductors. BMJ (1990) 0.75
Molecular pathology of Alzheimer's disease in sporadic and familial Alzheimer's disease with mutations in the amyloid precursor protein. Biochem Soc Trans (1992) 0.75
Treatment strategy for the corticocortical neuron pathology of Alzheimer's disease. Ann Neurol (1992) 0.75
Cerebral biopsy in the investigation of presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry (1986) 0.75
Semi-automatic quantification of regional cerebral perfusion in primary degenerative dementia using 99m technetium-hexamethylpropylene amine oxime and single photon emission tomography. Eur J Nucl Med (1990) 0.75
Working memory in Alzheimer's disease and frontotemporal dementia. Behav Neurol (2010) 0.75
Acute meningo-encephalitis in pregnancy-a problem of differential diagnosis. Eur J Neurol (1996) 0.75
Letter: Thymoxamine ineffective against spasticity. Lancet (1973) 0.75
Characteristics of lymphocyte chromatin from Alzheimer's disease patients and from young and old normal individuals. Gerontology (1989) 0.75
Molecular classification of the dementias. Lancet (2000) 0.75
Cerebral biopsy in the study of Alzheimer's disease. Bull Clin Neurosci (1985) 0.75